腹腔镜胃癌根治术治疗浆膜受侵局部进展期胃癌的远期结局
本研究为回顾性队列研究,纳入495例浆膜受侵局部进展期胃癌行腹腔镜胃癌根治术患者,5年无病生存率和总体生存率分别为56.0%和58.2%,多因素分析显示年龄>65岁、淋巴结清扫数目<25枚、病理学Ⅲ期及未辅助化疗是独立不良预后因素。
要点
- 浆膜受侵局部进展期胃癌腹腔镜根治术后5年无病生存率56.0%,总体生存率58.2%。
- 病理学Ⅲ期、未辅助化疗、淋巴结清扫<25枚、年龄>65岁为独立不良预后因素。
- 结论认为更多淋巴结清扫和规范辅助化疗有望进一步改善预后。
核心结论
- 腹腔镜胃癌根治术治疗浆膜受侵局部进展期胃癌远期肿瘤学效果满意。
- 更多的淋巴结清扫数目、术后行规范辅助化疗有望进一步提高此类患者腹腔镜胃癌根治术的预后。
研究设计与样本
- 本研究为回顾性队列研究,分析2012年10月至2018年10月陆军军医大学第一附属医院普通外科收治的495例行腹腔镜胃癌根治术的浆膜受侵局部进展期胃癌患者资料。
- 男性356例,女性139例,年龄[M(IQR)]59(16)岁(范围:18~75岁)。
主要发现
- 全部495例患者中57例失访,失访率11.5%,随访时间89(40)个月(范围:23~134个月)。
- 5年无病生存率和总体生存率分别为56.0%和58.2%。
- ⅡB、ⅢA、ⅢB、ⅢC期患者5年无病生存率分别为71.2%、60.5%、51.6%、33.3%,5年总体生存率分别为71.2%、62.2%、54.1%、39.3%。
- 多因素分析显示年龄>65岁(无病生存:HR=1.402,95%CI:1.022~1.922,P=0.036;总体生存:HR=1.461,95%CI:1.057~2.019,P=0.022)、淋巴结清扫数目<25枚(无病生存:HR=1.348,95%CI:1.019~1.779,P=0.036;总体生存:HR=1.376,95%CI:1.035~1.825,P=0.028)、病理学Ⅲ期(无病生存:HR=2.131,95%CI:1.444~3.144,P<0.01;总体生存:HR=2.079,95%CI:1.406~3.074,P<0.01)及未辅助化疗(无病生存:HR=3.127,95%CI:2.377~4.113,P<0.01;总体生存:HR=3.768,95%CI:2.828~5.020,P<0.01)是患者无病生存率及总体生存率的独立不良预后因素。
临床怎么用
- 原文结论认为腹腔镜胃癌根治术治疗浆膜受侵局部进展期胃癌可达到满意的远期肿瘤学效果。
- 作者认为更多的淋巴结清扫数目、术后行规范辅助化疗有望进一步提高此类患者的预后。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To evaluate the long-term outcomes and prognostic factors of locally advanced gastric cancer with serosa-invasion. Methods: This study is a retrospective cohort study. The clinical and pathological data of 495 patients with locally advanced gastric cancer with serosa-invasion who underwent laparoscopic radical gastrectomy in Department of General Surgery, the First Hospital Affiliated to Army Medical University from October 2012 to October 2018 was analyzed retrospectively. There were 356 males and 139 females with an age (M(IQR)) of 59 (16) years (range: 18 to 75 years). Observation indicators included postoperative results and long-term prognosis. The survival curve was drawn by the Kaplan-Meier method. Univariate and multivariate prognostic analysis was performed using the Cox proportional hazards model. Results: Among the 495 patients, a total of 57 patients (11.5%) were lost to follow-up, with a follow-up time of 89 (40) months (range: 23 to 134 months). The 5-year disease-free survival rate (DFS) and the 5-year overall survival rate (OS) were 56.0% and 58.2%, respectively. The 5-year DFS for patients with stage ⅡB, ⅢA, ⅢB, ⅢC were 71.2%, 60.5%, 51.6%, 33.3%, respectively. The 5-year OS for patients with stage ⅡB, ⅢA, ⅢB, ⅢC were 71.2%, 62.2%, 54.1%, 39.3%, respectively. Multivariate analysis showed that age >65 years (DFS: HR=1.402, 95%CI: 1.022 to 1.922, P=0.036; OS: HR=1.461, 95%CI: 1.057 to 2.019, P=0.022), lymph node dissection number less than 25 (DFS: HR=1.348, 95%CI: 1.019 to 1.779, P=0.036; OS: HR=1.376, 95%CI: 1.035 to 1.825, P=0.028), pathological stage Ⅲ (DFS: HR=2.131, 95%CI: 1.444 to 3.144, P<0.01; OS: HR=2.079, 95%CI: 1.406 to 3.074, P<0.01), and no postoperative chemotherapy (DFS: HR=3.127, 95%CI: 2.377 to 4.113, P<0.01; OS: HR=3.768, 95%CI: 2.828 to 5.020, P<0.01) were independent prognostic factors for the decrease in DFS and OS rates. Conclusions: Laparoscopic radical gastrectomy for locally advanced gastric cancer with serosa-invasion could achieve satisfactory long-term oncological outcomes. More lymph node dissection and standardized postoperative adjuvant chemotherapy are expected to further improve the prognosis of patients with locally advanced gastric cancer with serous invasion after laparoscopic radical surgery. 目的: 探讨腹腔镜胃癌根治术治疗浆膜受侵局部进展期胃癌的远期效果和预后因素。 方法: 本研究为回顾性队列研究。回顾性分析2012年10月至2018年10月陆军军医大学第一附属医院普通外科收治的495例行腹腔镜胃癌根治术的患者资料,男性356例,女性139例,年龄[M(IQR)]59(16)岁(范围:18~75岁)。观察和记录患者的术后情况和远期疗效。采用 Kaplan-Meier 法绘制生存曲线。影响患者预后的单因素及多因素分析采用 Cox 比例风险模型。 结果: 全部495例患者中,57例失访,失访率为11.5%。随访时间89(40)个月(范围:23~134个月)。5年无病生存率和总体生存率分别为56.0%和58.2%。ⅡB、ⅢA、ⅢB、ⅢC期患者5年无病生存率分别为71.2%、60.5%、51.6%、33.3%,5年总体生存率分别为71.2%、62.2%、54.1%、39.3%。多因素分析结果显示,年龄>65岁(无病生存:HR=1.402,95%CI:1.022~1.922,P=0.036;总体生存:HR=1.461,95%CI:1.057~2.019,P=0.022)、淋巴结清扫数目<25枚(无病生存:HR=1.348,95%CI:1.019~1.779,P=0.036;总体生存:HR=1.376,95%CI:1.035~1.825,P=0.028)、病理学Ⅲ期(无病生存:HR=2.131,95%CI:1.444~3.144,P<0.01;总体生存:HR=2.079,95%CI:1.406~3.074,P<0.01)及未辅助化疗(无病生存:HR=3.127,95%CI:2.377~4.113,P<0.01;总体生存:HR=3.768,95%CI:2.828~5.020,P<0.01)是患者无病生存率及总体生存率的独立不良预后因素。 结论: 腹腔镜胃癌根治术治疗浆膜受侵局部进展期胃癌远期肿瘤学效果满意。更多的淋巴结清扫数目、术后行规范辅助化疗有望进一步提高此类患者腹腔镜胃癌根治术的预后。.
引用
- Li PA, Zhang F, Li ZY, et al. [Long-term outcomes of laparoscopic gastrectomy for locally advanced gastric cancer with serosa-invasion]. Zhonghua Wai Ke Za Zhi. 2024. PMID: 38937125. doi:10.3760/cma.j.cn112139-20240131-00061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。